Enzalutamide ± Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
J. Clin. Oncol 2023 Mar 30;[EPub Ahead of Print], MJ Morris, G Heller, DW Hillman, O Bobek, C Ryan, ES Antonarakis, AH Bryce, O Hahn, H Beltran, AJ Armstrong, L Schwartz, LD Lewis, JH Beumer, B Langevin, EC McGary, PT Mehan, A Goldkorn, BJ Roth, H Xiao, C Watt, ME Taplin, S Halabi, EJ SmallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.